To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Report on Third Annual General Meeting Proceedings

Release Date: 13/11/2015 10:20
Code(s): ASC     PDF:  
Wrap Text
Report on Third Annual General Meeting Proceedings

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
JSE share code: ASC
ISIN: ZAE000185005
(“Ascendis of “the Company”)

Report on Third Annual General Meeting Proceedings

Ascendis shareholders are advised that at the Third Annual General Meeting of members held on
Thursday, 12th November 2015, all the ordinary and special resolutions as proposed in the Notice of the
Annual General Meeting were approved by the requisite majority of members. In this regard, Ascendis
confirms the voting results from the Third Annual General Meeting as follows:

                                                                                  %          Number
 Total number of shares that could be voted at meeting                         100%     270,232,494
 Total number of shares present/represented including proxies at meeting      74.51%    201,341,399
 Total number of members present/presented by representation                                    59


                                                   Votes in         Votes    Abstain         Shares
                                                     Favour        Against                   voted

 Ordinary Resolution Number 1                    201,341,399            0           0      201,341,399
 Adoption of Annual Financial Statements            100.00%         0.00%       0.00%          100.00%

 Ordinary Resolution Number 2                    201,341,399            0           0      201,341,399
 Re-appointment of auditors                         100.00%         0.00%       0.00%          100.00%

 Ordinary Resolution Number 3.1                  191,404,864            0    9,936,535     191,404,864
 Re-election of John Andrew Bester as a non-         100.00%         0.00%       3.68%         100.00%
 executive director                                 
 Ordinary Resolution Number 3.2                  191,404,864            0    9,936,535     191,404,864
 Re-election of Osment Philip Cunningham as a        100.00%         0.00%       3.68%         100.00%
 non-executive director     
                        
 Ordinary Resolution Number 4.1                  201,273,389        68,010           0     201,341,399
 Appointment of Kieron Futter as an executive         99.97%         0.03%       0.00%        100.00%     
 director                                             
 Ordinary Resolution Number 4.2                  191,336,854       68,010    9,936,535     191,404,864
 Appointment of Clifford Beck Sampson as an           99.96%        0.04%        3.68%         100.00%
 executive director                                   

 Ordinary Resolution Number 5.1                  191,404,864            0    9,936,535     191,404,864
 Appointment of Bharti Harie as a member of          100.00%         0.00%       3.68%         100.00%
 the Audit committee                                

 Ordinary Resolution Number 5.2                  190,835,914       568,950   9,936,535     191,404,864
 Appointment of John Andrew Bester as a               99.70%        0.30%        3.68%         100.00%
 member of the Audit committee                        

 Ordinary Resolution Number 5.3                  191,404,864            0    9,936,535     191,404,864
 Appointment of Osment Philip Cunningham as          100.00%         0.00%       3.68%         100.00%
 a member of the Audit committee                   
                                               
 Ordinary Resolution Number 6                    181,474,256    19,867,143            0    201,341,399
 General authority to issue shares of the             90.13%      9.87%           0.00%        100.00%
 Company  
                                             
 Special Resolution Number 1                     182,053,209    19,288,190            0    201,341,399
 General authority to issue shares of the             90.42%         9.58%        0.00%        100.00%
 Company for cash                                     

 Special Resolution Number 2                     201,341,399            0            0     201,341,399
 Approval of independent non-executive               100.00%         0.00%       0.00%         100.00%
 directors’ remuneration                           

 Special Resolution Number 3                     198,450,521      2,890,878           0    201,341,399
 General authority to repurchase shares in the        98.56%          1.44%       0.00%        100.00%
 Company                                              

 Special Resolution Number 4                     181,978,037     19,363,362           0    201,341,399
 Approval of financial assistance in terms of         90.38%          9.62%       0.00%        100.00%
 section 44 of the Companies Act                      

 Special Resolution Number 5                     181,409,087     19,932,312           0    201,341,399
 Approval of financial assistance in terms of         90.10%          9.90%       0.00%        100.00%
 section 45 of the Companies Act                      

 Ordinary Resolution Number 7                    197,809,116      3,532,283           0    201,341,399
 Endorsement of Ascendis’ Remuneration                98.25%          1.75%        0.00%       100.00%
 Policy                                               

 Ordinary Resolution Number 8                    201,341,399             0            0    201,341,399
 Authority to sign all documents                    100.00%          0.00%        0.00%        100.00%


Votes withheld are not votes in law and have not been counted in the calculation of the proportion of
votes 'for' or 'against' a resolution. Proxy appointments which gave discretion to the Chairman have been
included in the 'for' total.

Andy Sims
Company Secretary
Ascendis Health Limited

13 November 2015

Sponsor: Investec Bank Limited

Date: 13/11/2015 10:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.